TG Therapeutics Investigational Trial Site is a clinical research site located in Lexington, Kentucky, United States 40506.
Crixeo Health Trust Score: 61/100 (FAIR). This profile has not yet been claimed by the site owner.
TG Therapeutics Investigational Trial Site has participated in 4 clinical trials with 2 currently active.
Therapeutic areas: B-cell Mediated Autoimmune Disorders, Relapsing Remitting Multiple Sclerosis, Multiple Sclerosis.
Sponsors: TG Therapeutics, Inc..
Trust Score: 61/100. Verification status: Not yet accredited. Patient reviews: 0. Complaints: 0.
TG Therapeutics Investigational Trial Site has a Crixeo Trust Score of 61/100 (FAIR). Trust Scores reflect trial volume, sponsor diversity, patient reviews, address verification, and accreditation status.
TG Therapeutics Investigational Trial Site has 4 clinical trials on record, with 2 currently active. Their work covers B-cell Mediated Autoimmune Disorders, Relapsing Remitting Multiple Sclerosis, Multiple Sclerosis.
TG Therapeutics Investigational Trial Site has not yet obtained Crixeo Accreditation. Site owners can claim their profile and apply for accreditation to improve visibility with sponsors and patients.
Yes. Patients and trial participants can submit reviews and file complaints directly on this profile page. All submissions are reviewed before publication.